Filter
17
Filtered Results: 17
Text search:
G.
L.
Birbeck
Featured
Language
Document type
No document type
14
Studies & Reports
2
Guidelines
1
Countries / Regions
Latin America and the Carribbean
2
Nigeria
1
Africa
1
Spain
1
South Africa
1
Eastern Europe
1
Authors & Publishers
Publication Years
Category
COVID-19
1
Studies & Reports
1
Toolboxes
Epilepsy
8
Epilepsy
6
Neurological Disorders
5
Africa
3
Latin America
2
Children/Adolescents Mental Disorders
2
Latin America
2
Posttraumatic stress disorder Adults
1
Substance Use Disorders, Others
1
Interculturality
1
Eastern Europe
1
Africa
1
General Studies & Reports
1
Training Supporting Material mhGAP
1
Stress
1
Country specific documents
1
MHPSS – Psychosocial Support
1
Biontech/Pfizer Comirnaty
1
others
1
Substance Use Disorders & Addiction
1
Neurological disorders, Others
1
Objectives and scope of the document
This document was developed to provide recommended management strategies for problems and disorders that are specifically related to the occurrence of a major stressful event. The recommended strategies will form the basis of a new module to be added to the WHO ...
BMC Medicine201210:107
https://doi.org/10.1186/1741-7015-10-107© Katchanov and Birbeck; licensee BioMed Central Ltd. 2012
Received: 10 July 2012Accepted: 24 September 2012Published: 24 September 2012
In 2011, the World Health Organization’s (WHO) mental health Gap Action Programme (mhGAP) r...
Brief review of selected topics
The following pages provide a focus on selected areas in relation to neurology. The specialists who contributed the reviews are listed in the Project Team and Partners
Neurology Atlas (2004)
SCOPING QUESTION: For adults and children with medication-resistant convulsive epilepsy, which anti-epileptic medications produce benefits and/or harm in the specified outcomes when compared to a placebo or a comparator?
The Global Burden of Disease (GBD) study, a collaborative endeavour of the World
Health Organization (WHO), the World Bank and the Harvard School of Public Health,
drew the attention of the international health community to the burden of neurological
disorders and many other chronic conditions. T...
Epilepsy is one of the world’s most common chronic neurological disorders. Roughly 50 million people
suffer from it, 5 million of them in the Region of the Americas . Nevertheless, it is estimated that over
50% of these people in Latin America and the Caribbean have no access to services. Furthe...
October 2009 | Volume 6 | Issue 10 | e1000162
www.jogh.org • doi: 10.7189/jogh.02.020405 ~ December 2012 • Vol. 2 No. 2 • 020405
Scoping Question: For adults and children living with HIV, which antiepileptic medications (such as phenobarbital, phenytoin, carbamazepine or valproic acid) produce benefits and/or harms when compared to a placebo or controls?
Harm reduction: evidence, impacts and challenges
-10-
Received: 16/11/2013 - Accepted: 23/03/2014 - Published: 27/07/2014
The WHO Regional Office for Europe, the WHO Collaborating Centre on Culture and Health at the University of Exeter (United Kingdom) and the National Institute of Mental Health (Czechia) convened a workshop on culture and reform of mental health care in central and eastern Europe on 2–3 October 201...
This article was published on December 10, 2020, and updated on December 16, 2020, at NEJM.org. DOI: 10.1056/NEJMoa2034577
Download (7.4 MB)
Overview
Epilepsy is one of the most common neurological disorders globally. The WHO epilepsy technical brief aims to strengthen action for epilepsy and complements the Intersectoral global action plan on epilepsy and other neurological disorders 2022–2031.
The technical bri...
